{"id":79427,"date":"2026-09-08T12:57:32","date_gmt":"2026-09-08T04:57:32","guid":{"rendered":"https:\/\/flcube.com\/?p=79427"},"modified":"2026-09-08T12:57:33","modified_gmt":"2026-09-08T04:57:33","slug":"sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system","status":"publish","type":"post","link":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/","title":{"rendered":"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop &#8220;AI Design + Wet\u2011Lab Validation&#8221; Discovery System"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Beijing Sun-Novo Pharmaceutical Research Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/688621:SHA\">SHA: 688621<\/a>) and <strong>DeepMed Technology (Suzhou) Co., Ltd.<\/strong> have officially signed a <strong>strategic cooperation agreement on AI\u2011driven drug research and development<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-deal-milestone\" class=\"wp-block-heading\">Deal Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Party A<\/strong><\/td><td>Beijing Sun\u2011Novo Pharmaceutical Research Co., Ltd. (SHA: 688621) \u2014 leading integrated new drug R&amp;D complex in China<\/td><\/tr><tr><td><strong>Party B<\/strong><\/td><td>DeepMed Technology (Suzhou) Co., Ltd. \u2014 AI\u2011driven application and translation platform empowering biopharmaceutical innovation<\/td><\/tr><tr><td><strong>Agreement Type<\/strong><\/td><td>Strategic cooperation agreement on <strong>AI\u2011driven drug R&amp;D<\/strong><\/td><\/tr><tr><td><strong>Core Model<\/strong><\/td><td>Closed\u2011loop system combining <strong>&#8220;AI in silico intelligent design + traditional wet\u2011lab validation and translation&#8221;<\/strong><\/td><\/tr><tr><td><strong>Scope<\/strong><\/td><td>Dedicated therapeutic areas; long\u2011term collaborative development for specific targets and projects<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Build a <strong>differentiated pipeline of innovative drug candidates<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-partnership-structure-closed-loop-r-amp-d-system\" class=\"wp-block-heading\">Partnership Structure \u2014 Closed\u2011Loop R&amp;D System<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Within dedicated therapeutic areas, the two parties will jointly establish a closed\u2011loop new drug R&amp;D system:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Role<\/th><\/tr><\/thead><tbody><tr><td><strong>AI in silico intelligent design<\/strong> (DeepMed)<\/td><td>Computational target identification, molecular design, and candidate optimization<\/td><\/tr><tr><td><strong>Wet\u2011lab validation and translation<\/strong> (Sun\u2011Novo)<\/td><td>Experimental confirmation and translational development within an integrated R&amp;D complex<\/td><\/tr><tr><td><strong>Long\u2011term collaboration<\/strong><\/td><td>Joint development for specific targets and projects, strategically building a differentiated pipeline<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-key-technology-areas\" class=\"wp-block-heading\">Key Technology Areas<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Nano\u2011targeted antibody discovery and engineering<\/strong> for delivery systems<\/li>\n\n\n\n<li><strong>Therapeutic or targeted cyclic peptide design<\/strong><\/li>\n\n\n\n<li><strong>RNA\u2011targeted small\u2011molecule compound discovery<\/strong><\/li>\n\n\n\n<li><strong>Multi\u2011target small\u2011molecule drug discovery<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI Drug Discovery Goes Closed\u2011Loop:<\/strong> By pairing DeepMed&#8217;s in silico design engine with Sun\u2011Novo&#8217;s wet\u2011lab validation infrastructure, the partnership addresses a core bottleneck in AI\u2011driven discovery \u2014 the iterative feedback cycle between computational prediction and experimental confirmation.<\/li>\n\n\n\n<li><strong>Modality Breadth:<\/strong> The four technology areas span the industry&#8217;s fastest\u2011growing modalities \u2014 antibodies, cyclic peptides, RNA\u2011targeted small molecules, and multi\u2011target agents \u2014 positioning the pipeline for differentiation beyond conventional single\u2011target small molecules.<\/li>\n\n\n\n<li><strong>Listed\u2011Company Exposure:<\/strong> For <strong>Sun\u2011Novo<\/strong> (SHA: 688621), the agreement accelerates pipeline diversification through an asset\u2011light AI partnership rather than wholly in\u2011house discovery spending.<\/li>\n\n\n\n<li><strong>Platform Validation for DeepMed:<\/strong> A long\u2011term strategic tie with an established Chinese R&amp;D complex extends DeepMed&#8217;s translation track record across multiple modalities and therapeutic areas.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding AI\u2011driven discovery programs, pipeline development, and collaboration outcomes. Actual results may differ due to risks including research feasibility, preclinical and clinical outcomes, regulatory timelines, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA: 688621) and DeepMed Technology (Suzhou) Co., Ltd. have&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[99,4941,1262,2604],"class_list":["post-79427","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-ai","tag-deepmed-technology","tag-sha-688621","tag-sun-novo-pharmaceutical-research"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop &quot;AI Design + Wet\u2011Lab Validation&quot; Discovery System - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA: 688621) and DeepMed Technology (Suzhou) Co., Ltd. have officially signed a strategic cooperation agreement on AI\u2011driven drug research and development.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop &quot;AI Design + Wet\u2011Lab Validation&quot; Discovery System\" \/>\n<meta property=\"og:description\" content=\"Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA: 688621) and DeepMed Technology (Suzhou) Co., Ltd. have officially signed a strategic cooperation agreement on AI\u2011driven drug research and development.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-08T04:57:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T04:57:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop &#8220;AI Design + Wet\u2011Lab Validation&#8221; Discovery System\",\"datePublished\":\"2026-09-08T04:57:32+00:00\",\"dateModified\":\"2026-09-08T04:57:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/\"},\"wordCount\":428,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"DeepMed Technology\",\"SHA: 688621\",\"Sun-Novo Pharmaceutical Research\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/\",\"name\":\"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop \\\"AI Design + Wet\u2011Lab Validation\\\" Discovery System - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-09-08T04:57:32+00:00\",\"dateModified\":\"2026-09-08T04:57:33+00:00\",\"description\":\"Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA: 688621) and DeepMed Technology (Suzhou) Co., Ltd. have officially signed a strategic cooperation agreement on AI\u2011driven drug research and development.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop &#8220;AI Design + Wet\u2011Lab Validation&#8221; Discovery System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/author\\\/wesley\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop \"AI Design + Wet\u2011Lab Validation\" Discovery System - Insight, China&#039;s Pharmaceutical Industry","description":"Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA: 688621) and DeepMed Technology (Suzhou) Co., Ltd. have officially signed a strategic cooperation agreement on AI\u2011driven drug research and development.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/","og_locale":"en_US","og_type":"article","og_title":"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop \"AI Design + Wet\u2011Lab Validation\" Discovery System","og_description":"Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA: 688621) and DeepMed Technology (Suzhou) Co., Ltd. have officially signed a strategic cooperation agreement on AI\u2011driven drug research and development.","og_url":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-09-08T04:57:32+00:00","article_modified_time":"2026-09-08T04:57:33+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/#article","isPartOf":{"@id":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop &#8220;AI Design + Wet\u2011Lab Validation&#8221; Discovery System","datePublished":"2026-09-08T04:57:32+00:00","dateModified":"2026-09-08T04:57:33+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/"},"wordCount":428,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","DeepMed Technology","SHA: 688621","Sun-Novo Pharmaceutical Research"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/","url":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/","name":"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop \"AI Design + Wet\u2011Lab Validation\" Discovery System - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-09-08T04:57:32+00:00","dateModified":"2026-09-08T04:57:33+00:00","description":"Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA: 688621) and DeepMed Technology (Suzhou) Co., Ltd. have officially signed a strategic cooperation agreement on AI\u2011driven drug research and development.","breadcrumb":{"@id":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/sun-novo-pharmaceutical-and-deepmed-technology-sign-strategic-pact-on-ai-driven-drug-rd-building-closed-loop-ai-design-wet-lab-validation-discovery-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Sun-Novo Pharmaceutical and DeepMed Technology Sign Strategic Pact on AI\u2011Driven Drug R&amp;D \u2013 Building Closed\u2011Loop &#8220;AI Design + Wet\u2011Lab Validation&#8221; Discovery System"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/author\/wesley\/"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/comments?post=79427"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79427\/revisions"}],"predecessor-version":[{"id":79430,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79427\/revisions\/79430"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/media?parent=79427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/categories?post=79427"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/tags?post=79427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}